Related references
Note: Only part of the references are listed.A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy
James R. Burton et al.
JOURNAL OF HEPATOLOGY (2014)
Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience
Audrey Coilly et al.
JOURNAL OF HEPATOLOGY (2014)
SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF RECURRENT HEPATITIS C INFECTION AFTER LIVER TRANSPLANTATION: RESULTS OF A PROSPECTIVE, MULTICENTER STUDY
D. Samuel et al.
JOURNAL OF HEPATOLOGY (2014)
A Randomized Controlled Trial of Pretransplant Antiviral Therapy to Prevent Recurrence of Hepatitis C After Liver Transplantation
Gregory T. Everson et al.
HEPATOLOGY (2013)
SVR12 RATES AND SAFETY OF TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR IN 221 CIRRHOTIC NON RESPONDERS TREATED IN THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC)
H. Fontaine et al.
JOURNAL OF HEPATOLOGY (2013)
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)-NCT01514890
Christophe Hezode et al.
JOURNAL OF HEPATOLOGY (2013)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Retreatment of HCV Infection
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Liver Transplantation in the United States, 1999-2008
P. J. Thuluvath et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Paul Y. Kwo et al.
LANCET (2010)
Telaprevir for Previously Treated Chronic HCV Infection.
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
Thierry Poynard et al.
GASTROENTEROLOGY (2009)
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study
Jose A. Carrion et al.
JOURNAL OF HEPATOLOGY (2009)
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hezode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial
Gregory T. Everson et al.
HEPATOLOGY (2006)
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy
GT Everson et al.
HEPATOLOGY (2005)
Infection with chronic hepatitis C virus and liver transplantation: A role for interferon therapy before transplantation
RM Thomas et al.
LIVER TRANSPLANTATION (2003)
Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation
X Forns et al.
JOURNAL OF HEPATOLOGY (2003)
A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation
JS Crippin et al.
LIVER TRANSPLANTATION (2002)
Share Paper
